Uniplan Investment Counsel’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-230,663
Closed -$1.57M 203
2025
Q3
$1.57M Sell
230,663
-38,466
-14% -$318K 0.15% 129
2025
Q2
$3.67M Sell
269,129
-119,159
-31% -$1.13M 0.37% 68
2025
Q1
$2.11M Buy
388,288
+3,035
+0.8% +$17.2K 0.21% 101
2024
Q4
$1.91M Sell
385,253
-5,099
-1% -$26.7K 0.18% 103
2024
Q3
$2.05M Sell
390,352
-6,849
-2% -$39.5K 0.18% 106
2024
Q2
$2.72M Buy
397,201
+184,143
+86% +$1.68M 0.25% 89
2024
Q1
$2.19M Buy
213,058
+91,768
+76% +$678K 0.17% 101
2023
Q4
$1.01M Buy
+121,290
New +$872K 0.08% 118

Other funds holding LFMD

Uniplan Investment Counsel's LFMD Position: Q4 2025 in Review

Uniplan Investment Counsel sold out of LifeMD (LFMD) in Q4 2025, closing a stake of 230,663 shares — an estimated $1.57M sold.

Uniplan Investment Counsel first reported a position in LFMD in Q4 2023 and held it in 8 quarters. The position peaked at $3.67M in Q2 2025. 104 funds tracked by Wall St. Rank hold LFMD as of Q4 2025.

  • Uniplan Investment Counsel reported no remaining LifeMD position as of Q4 2025 after selling out during the quarter.
  • Uniplan Investment Counsel sold 230,663 LifeMD shares in Q4 2025, an estimated $1.57M.
  • Uniplan Investment Counsel first reported a position in LifeMD in Q4 2023 and held it in 8 quarters.
  • Uniplan Investment Counsel's LifeMD position peaked at $3.67M in Q2 2025.
  • 104 funds tracked by Wall St. Rank held LifeMD as of Q4 2025.

Based on Uniplan Investment Counsel's 13F filing for Q4 2025, filed 17 Feb 2026.